Influence of IPV on GOR in Infants From 0 to 12 Months.
NCT ID: NCT02124863
Last Updated: 2017-02-10
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
67 participants
INTERVENTIONAL
2013-09-30
2015-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-invasive Ventilation in Preterm Infants
NCT05987800
Safety Study of Airway Clearance Techniques in Infants.
NCT02128867
Safety and Efficacy of Intrapulmonary Percussive Ventilation in Preterm Infants
NCT06229821
Influence of Positive-End-Expiratory-Pressure (PEEP) on Cardiac Output in Mechanically Ventilated Children
NCT06270485
sNIPPV Versus NIV-NAVA in Extremely Premature Infants
NCT04068558
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intrapulmonary Percussive Ventilation
number of refluxes during 20 min of IPV ( rate : 300/min, p = 10cmH2O) at least 120 min after feeding
Intrapulmonary Percussive Ventilation
20 min IPV freq 300/min, p 10cmH2O
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intrapulmonary Percussive Ventilation
20 min IPV freq 300/min, p 10cmH2O
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* impedance monitoring
Exclusion Criteria
* anti-reflux medication
* Nissen fundoplication
* no parental consent
1 Day
12 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vrije Universiteit Brussel
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Filip Van Ginderdeuren
PT, Drs
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
fili van ginderdeuren
Role: PRINCIPAL_INVESTIGATOR
Vrije Universiteit Brussel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UZ Brussel
Jette, Brussels Capital, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FVG002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.